VNDL
  • Home
  • Search
  • Contact
  • More
    • Methodology
    • Video Library
    • External Resources
    • FAQ
<Return to Disease List
Gangliosidosis Type 1 (GM1)​
  • Description
  • Signalment
  • Clinical Features
  • Neurolocalization
  • Genetics
<
>
Gangliosidosis (GM1) is an inherited deficiency in the enzyme beta-galactosidase which causes defects in the catabolism of gangliosides resulting in their accumulation in neuron lysosomes.
Age of Onset: 5-7 months of age
Sex Predisposition: Any sex of animal can be affected
Clinical Course:
​ Clinical signs worsen over time
Clinical Signs: 
Behavioral/Mental Awareness 
Aggression
Dementia
Seizures 

Posture and Appearance
Wide-based stance

Movement 
Ataxia
Hypermetria
Head Tremor
Spastic Paraplegia or Tetraplegia
​
Spinal Reflexes
Hyperreflexia/Normoreflexia

Cranial Nerves 
Visual Impairment
Nystagmus
Absent menace response


Other 
Death
Diffuse central nervous system
 Autosomal recessive GLB1 gene mutation 

For breed-specific genetic testing, click the link(s) below:

https://www.genomia.cz/en/test/gm1/
https://www.wisdompanel.com/en-us/dog-health-conditions/gm1-gangliosidosis-portuguese
​https://labogen.com/en/genetic-diseases-dog/gm1-gangliosidosis-gm1/
To read more about this disease click below:
References
Picture
Contact us:
[email protected]

Privacy Policy
Terms and Conditions​
Disclaimer
  • Home
  • Search
  • Contact
  • More
    • Methodology
    • Video Library
    • External Resources
    • FAQ